跳至主要内容
临床试验/IRCT2013041112977N1
IRCT2013041112977N1已完成2 期

The effect of clidinium c with triple therapy in comparison with standard triple therapy for helicobacter pylori eradication in peptic ulcer patients

Vice chancellor for research, Golestan University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with peptic ulcer in endoscopy and positive rapid urease test for helicobacter pylori (HP) infection are enrolled.
  • Exclusion criteria: Patients that are taking non steroid anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs), bismuth preparations or antibiotics during the last four weeks and with prior HP eradication, glaucoma, prostatic hypertrophy, pregnancy , lactation and intolerable side effects of clidinium-c are excluded.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Golestan University of Medical Sciences

相似试验